Maravai Lifesciences Holdings (MRVI) Interest Coverage Ratio (2020 - 2026)
Maravai Lifesciences Holdings' (MRVI) quarterly Interest Coverage Ratio came in at 0.35 in Q1 2026, up 81.34% year-on-year from 0.19 in Q1 2025, and up 95.09% quarter-over-quarter from 7.15 in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 0.35 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 81.34% year-over-year to 0.35 in Q1 2026; TTM through Mar 2026 was 4.48, a 55.99% increase from a year earlier, with the FY2025 full-year figure at 6.25, down 1738.05% from the prior year.
- Interest Coverage Ratio grew to 0.35 in Q1 2026 per MRVI's latest filing, from 7.15 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 10.96 in Q4 2022 and bottomed at 7.15 in Q4 2025.
- The 5-year median for Interest Coverage Ratio is 0.59 (2023), against an average of 0.16.
- Across the five-year window, Interest Coverage Ratio slumped 1699.75% in 2024 and surged 81.34% in 2026, its largest moves.
- Year by year, Interest Coverage Ratio stood at 10.96 in 2022, then slumped by 104.23% to 0.46 in 2023, then slumped by 620.98% to 3.35 in 2024, then slumped by 113.65% to 7.15 in 2025, then jumped by 95.09% to 0.35 in 2026.
- Per Business Quant, the three latest MRVI Interest Coverage Ratio figures stand at 0.35 (Q1 2026), 7.15 (Q4 2025), and 1.56 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn | -0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | -7.15 |
| Sep 30, 2025 | -1.56 |
| Jun 30, 2025 | -2.53 |
| Mar 31, 2025 | -1.88 |
| Dec 31, 2024 | -3.35 |
| Sep 30, 2024 | -6.37 |
| Jun 30, 2024 | -1.13 |
| Mar 31, 2024 | -1.55 |
| Dec 31, 2023 | -0.46 |
| Sep 30, 2023 | -0.59 |
| Jun 30, 2023 | -0.45 |
| Mar 31, 2023 | 0.10 |
| Dec 31, 2022 | 10.96 |
| Sep 30, 2022 | 4.78 |
| Jun 30, 2022 | 7.40 |
| Mar 31, 2022 | 6.85 |
| Dec 31, 2021 | 22.01 |
| Sep 30, 2021 | 10.78 |
| Jun 30, 2021 | 10.65 |